SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is a major talking point as geopolitical focus intensifies on Greenland's strategic rare earth deposits, highlighted by U.S. administration comments. The community widely discusses the potential for government investment or partnership, viewing CRML's Tanbreez project as vital for Western supply chain independence from key mineral producing nations and speculating on substantial gains.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy (MSTR) is experiencing significant buzz following MSCI's decision not to exclude digital asset treasury companies from its indexes, dispelling a major bearish concern. This news is fueling anticipation of a substantial rally and short squeezes among bulls who believe the stock was undervalued, though some skeptics remain focused on potential dilution and Bitcoin's volatile price action.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust ($SLV) is experiencing significant speculative interest, fueled by discussions around tight physical supply, escalating industrial demand, and broader geopolitical concerns. Bulls are confidently predicting new all-time highs and a "new paradigm" for silver, while bears are vehemently warning of an unsustainable "bubble" ripe for a sharp correction, sparking a heated debate within the community.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU CRYPTO is trending due to its exceptionally active and dedicated community, which is relentlessly building a permissionless brand with real-world products and extensive IRL presence. The community, active across multiple chains, passionately believes KENDU is an unstoppable long-term play, often declaring it destined to become a household name.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as the community eagerly anticipates the completion of its Northern Data acquisition, poised to significantly expand its AI and cloud capabilities. This move, coupled with substantial investment and service commitments from Tether, fuels widespread discussion about a potential short squeeze due to high short interest, alongside excitement for the imminent Rumble Wallet launch and the return of key content creators.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending after experiencing a sharp price drop, which many in the community attribute to competitive downgrades from Bank of America and Goldman Sachs following a recent equity offering. Investors are actively debating whether this is market manipulation by legacy institutions to acquire shares at a lower price, especially ahead of highly anticipated earnings and potential S&P 500 inclusion. Despite the decline, many view the dip as a strategic buying opportunity, confident in SoFi's long-term prospects as a fintech disruptor.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is experiencing immense investor interest, driven by the surging demand for memory and storage within the AI supercycle and reports of deepening industry shortages. The community is sharply divided, with bulls pointing to its market-leading momentum and short squeeze potential, while skeptics question the sustainability of its rapid ascent. This intense discussion reflects broader sector strength in AI infrastructure.

Terrestrial Energy, Inc. is an advanced nuclear technology company focused on next-generation nuclear energy systems. The company is developing the Integral Molten Salt Reactor (IMSR), an innovative type of Generation IV molten salt reactor designed to produce reliable, low-carbon heat and electricity at competitive costs. The company is headquartered in Charlotte, NC.

Terrestrial Energy Inc.

Terrestrial Energy (IMSR) is trending following a significant agreement with the U.S. Department of Energy for Project TETRA, propelling its Integral Molten Salt Reactor technology toward pilot operation. The community is actively discussing IMSR as a potential leader in advanced nuclear energy, drawing comparisons to OKLO and highlighting its role in meeting future energy demands driven by AI and government initiatives. Many anticipate substantial upside as the company advances this pivotal, government-backed project in the burgeoning nuclear sector.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as market participants digest a major competitor's oral GLP-1 launch and its potential impact on pricing and competition. Community sentiment is sharply divided, with advocates highlighting VK2735's strong clinical profile and anticipating upcoming catalysts like the J.P. Morgan conference and FDA feedback on its oral program, while critics point to management's "go it alone" stance and recent insider share sales as causes for concern. This intense debate plays out against the backdrop of an expanding yet highly competitive obesity treatment landscape.

Ventyx Biosciences, Inc. engages in developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. The company was founded by Raju S. Mohan on November 21, 2018 and is headquartered in San Diego, CA.

Ventyx Biosciences Inc

Ventyx Biosciences is trending significantly following reports that Eli Lilly is nearing a deal to acquire the company for over $1 billion. This potential buyout has ignited widespread community discussion about the strategic value of Ventyx's oral inflammatory-disease drugs, especially its NLRP3 inhibitors, and their synergistic potential with major pharmaceutical pipelines. Many are actively speculating on the final acquisition price and the potential for a substantial short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zymeworks (NYSE:ZYME) CEO Sells $1,364,009.30 in Stock

Zymeworks Inc. (NYSE:ZYME - Get Free Report) CEO Kenneth Galbraith sold 54,343 shares of the firm's stock in a transaction that occurred on Monday, January 5th. The stock was sold at an average price...

Jeffrey Smith Sells 10,538 Shares of Zymeworks (NYSE:ZYME) Stock

Zymeworks Inc. (NYSE:ZYME - Get Free Report) EVP Jeffrey Smith sold 10,538 shares of the company's stock in a transaction on Monday, January 5th. The shares were sold at an average price of $25.10...

Paul Andrew Moore Sells 20,110 Shares of Zymeworks (NYSE:ZYME) Stock

Zymeworks Inc. (NYSE:ZYME - Get Free Report) insider Paul Andrew Moore sold 20,110 shares of the company's stock in a transaction dated Monday, January 5th. The shares were sold at an average price...

Insider Selling: Zymeworks (NYSE:ZYME) CEO Sells 54,343 Shares of Stock

Zymeworks Inc. (NYSE:ZYME - Get Free Report) CEO Kenneth Galbraith sold 54,343 shares of the firm's stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average...

Zymeworks (NASDAQ:ZYME) Stock Price Down 6.8% - What's Next?

Zymeworks (NASDAQ:ZYME) Shares Down 6.8% - What's Next...

Zymeworks (NYSE:ZYME) Stock Price Down 6.1% - Should You Sell?

Zymeworks (NYSE:ZYME) Stock Price Down 6.1% - Time to Sell...

Short Interest in Zymeworks Inc. (NASDAQ:ZYME) Drops By 29.8%

Zymeworks Inc. (NASDAQ:ZYME - Get Free Report) was the recipient of a large decrease in short interest in the month of December. As of December 15th, there was short interest totaling 3,938,970...

Zymeworks (NYSE:ZYME) CEO Sells $1,284,206.56 in Stock

Zymeworks Inc. (NYSE:ZYME - Get Free Report) CEO Kenneth Galbraith sold 47,528 shares of the company's stock in a transaction that occurred on Monday, December 22nd. The shares were sold at an...

Kenneth Galbraith Sells 47,528 Shares of Zymeworks (NYSE:ZYME) Stock

Zymeworks Inc. (NYSE:ZYME - Get Free Report) CEO Kenneth Galbraith sold 47,528 shares of the firm's stock in a transaction on Monday, December 22nd. The stock was sold at an average price of $27.02...

Zymeworks Inc. $ZYME Shares Purchased by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. raised its stake in Zymeworks Inc. (NYSE:ZYME - Free Report) by 169.2% during the third quarter, according to its most recent disclosure with the SEC. The fund owned...

Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Zanidatamab's unique binding properties result in multiple mechanisms of action that may enable it to address unmet need in patient populations with HER2-expressing cancers. The company was founded on September 8, 2003 and is headquartered in Middletown, DE.

Zymeworks BC Inc

Physical AI Infrastructure

Power & Energy to Support Growth

Healthcare Value & Innovation

Other – Comment Below

As markets head into 2026, investors are debating whether the next phase favors speculation or real-world execution. With capital rotating toward infrastructure, energy, and undervalued sectors like healthcare, which area do you think will matter most for portfolios in the year ahead?

Which Theme Will Matter Most for Portfolios in 2026?

ZYME
Zymeworks Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ZYME News

ZYMEZymeworks Inc